Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-22-076290
Filing Date
2022-03-15
Accepted
2022-03-15 17:15:11
Documents
12

Document Format Files

Seq Description Document Type Size
1 424B3 d268419d424b3.htm 424B3 35919
2 GRAPHIC g268419g0316004728819.jpg GRAPHIC 3962
3 GRAPHIC g335730g001v1.jpg GRAPHIC 61654
4 GRAPHIC g335730g002v1.jpg GRAPHIC 153031
5 GRAPHIC g335730g003v1.jpg GRAPHIC 47324
6 GRAPHIC g335730g004v1.jpg GRAPHIC 56417
7 GRAPHIC g335730g005v1.jpg GRAPHIC 65668
8 GRAPHIC g335730g006v1.jpg GRAPHIC 52378
9 GRAPHIC g335730g007v1.jpg GRAPHIC 55522
10 GRAPHIC g335730g008v1.jpg GRAPHIC 44456
11 GRAPHIC g335730g009v1.jpg GRAPHIC 52460
12 GRAPHIC g335730g010v1.jpg GRAPHIC 91787
  Complete submission text file 0001193125-22-076290.txt   981481
Mailing Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036
Business Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036 646-493-6558
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1028
Type: 424B3 | Act: 33 | File No.: 333-261383 | Film No.: 22742232
SIC: 8000 Services-Health Services